For example, the expression of another possible tumor suppressor, LRIG2, in early-stage erythrocytes and monocytes is accurately predicted (p-value <0.01) using K562 CRMs, but its expression in late-stage erythrocytes and monocytes is not predicted accurately. This evidence concerns the gene LRIG2 and neoplasm.